Loading organizations...
Beijing Yuan Xin is an integrated digital healthcare platform based in Beijing, China, that provides online medical consultations, prescription pharmacy networks, and health insurance administration services. The company operates a network of over 320 out-of-hospital pharmacies spanning 157 cities across 30 Chinese provinces, primarily serving patients requiring chronic disease management and specialized cancer treatments. In 2023, the enterprise generated approximately RMB 9.44 billion in revenue through the retail sale of prescription drugs, digital health management fees, and insurance brokerage premiums. Following multiple venture funding rounds, the organization successfully completed its initial public offering on the Hong Kong Stock Exchange in April 2024. Prior to its public listing, the healthcare provider secured financial backing from prominent institutional investors including Tencent, Sequoia Capital China, Qiming Venture Partners, and OrbiMed. Beijing Yuan Xin was founded in 2015 by He Tao.
Beijing Yuan Xin has raised $854.6M across 4 funding rounds.
Beijing Yuan Xin has raised $854.6M in total across 4 funding rounds.
Beijing Yuan Xin has raised $854.6M across 4 funding rounds. Most recently, it raised $231.5M Series F in August 2021.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Aug 12, 2021 | $231.5M Series F | — | AB Initio Capital, B Capital Group, CITIC Securities, Future Innovation, HEL VED, Stella Zhou, Index Capital, Kunling Capital, OrbiMed, Sequoia Capital, Springhill, UOB | Announced |
| Feb 9, 2021 | $465.3M Series E | Hongshan Capital Group (Sequoia Capital China), Tencent Holdings | — | Announced |
| Jun 15, 2020 | $84.7M Series D | — | — | Announced |
| Jan 9, 2019 | $73.1M Series C | Starquest Capital | — | Announced |
Beijing Yuan Xin has raised $854.6M in total across 4 funding rounds.
Beijing Yuan Xin's investors include Ab Initio Capital, B Capital Group, CITIC Securities, Future Innovation, Hel Ved, Stella Zhou, Index Capital, Kunling Capital, OrbiMed, Sequoia Capital, Springhill, UOB.
